Artemis Medicare Services Limited

BSE: 542919 NSE: ARTEMISMED
Artemis Medicare Services Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN L85110DL2004PLC126414 Incorporated 18 May 2004 ROC Delhi HQ New Delhi, Delhi, India
Active Listed - NSE: ARTEMISMED · BSE: 542919 Public Limited Company healthcare
Data last updated
Market Cap
₹4,490 Cr
ARTEMISMED · NSE
Share Price
₹285.10
+0.53% today
Revenue
₹1,081 Cr
FY 2025-26 · +15.4% YoY
EBITDA
₹185 Cr
Margin 17.1%
Net Profit
₹106 Cr
FY 2025-26 · +28.1% YoY
P/E (TTM)
40.0x
P/B 5.4x
ROE
12.7%
ROCE 15.1%
Debt / Equity
0.34
Interest cover 20.2x

About Artemis Medicare Services Limited

Data last updated:

Artemis Medicare Services Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Constructive Finance Private Limited. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 18 May 2004 and has been in existence for over 22 years.

Its director Onkar Kanwar is #278 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L85110DL2004PLC126414. Its GSTIN is 07AAFCA0130M1ZZ (Delhi). The company holds 5 GST registrations, of which 3 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 542919 and NSE: ARTEMISMED.

The company has an authorised share capital of ₹70.05 Cr and a paid-up capital of ₹15.83 Cr. It was formerly known as Artemis Medicare Services Private Limited. It is led by directors including Devlina Chakravarty (Managing Director) and Shalini Kanwar Chand.

Its last annual general meeting (AGM) was held on 30 July 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 14 Sector 20, New Delhi, Delhi, India – 110075.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,081.24 Cr, a growth of 15.4% compared to the previous year. For the same year it recorded a net profit of ₹105.9 Cr (net margin 9.8%) and EBITDA of ₹185.1 Cr (EBITDA margin 17.1%). The net worth stands at ₹934.71 Cr (up 11.6% YoY). Total assets are valued at ₹1,216.99 Cr (up 6.1% YoY).

The company has about 2,023 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Artemis Hospital. As per MCA filings, the company has open charges of ₹394.37 Cr and satisfied charges of ₹485.37 Cr on record. Court records list 38 cases involving the company, including 23 filed by the company and 16 filed against it; 11 cases are pending. The company has 6 deals on record (2 acquisitions, 1 convertible or debt financing, 1 funding round), with disclosed funding of ₹372.35 Cr; the latest was in September 2026. Its 8 peer companies in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities) are compared by revenue, 4 larger and 4 smaller; the largest is Malabar Institute of Medical Sciences Ltd with revenue of ₹1,127.68 Cr. The company has 4 MSME Form 1 returns on record for the period ending Mar 2019, listing 99 overdue payments to 15 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website artemishospitals.com.

Company details

CIN L85110DL2004PLC126414
Registration Number 126414
Incorporation Date 18 May 2004
ROC Delhi
Listing Status Listed - Listed on NSE (ARTEMISMED); Listed on BSE (542919)
Company Status Active
Date of Last AGM 30 July 2025
Date of Balance Sheet 31 March 2026
Parent Company Constructive Finance Private Limited
Compliance Status Active Compliant

CIN history

Artemis Medicare Services has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110DL2004PLC126414, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L85110DL2004PLC126414Current
U85110DL2004PTC126414Previous
U85110DL2004PLC126414Previous
Key People
Devlina Chakravarty Managing Director Shalini Kanwar Chand Director Onkar Kanwar Director

Recognitions & Rankings of Artemis Medicare Services

India's Richest People 2026 edition · 1 director · Source: Hurun India

Contact details

Artemis Medicare Services Limited's registered office is in New Delhi, Delhi. Its website is artemishospitals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    artemishospitals.com
  • Social Media
  • Apps
  • Registered Address
    Plot No. 14 Sector 20, New Delhi, Delhi, India – 110075
  • Industry
    Healthcare, Hospitals

To see the full contact details of Artemis Medicare Services Limited, buy the company report.

Comprehensive company report
Artemis Medicare Services Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Artemis Medicare Services operates one associated brand: Artemis Hospital. Each brand links to its own profile.

BrandDescriptionWebsite
Artemis Hospital
Multispecialty medical services are delivered in Gurugram, India.artemishospitals.com

Business activity

The main business activity of Artemis Medicare Services is hospital and medical care. In detail, this covers hospital activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ1Hospital activities

To see the full business activity and turnover split of Artemis Medicare Services Limited, buy the company report.

Financials of Artemis Medicare Services Limited

FY 2025-26 filings available

Artemis Medicare Services Limited reported revenue of ₹1,081.24 Cr (up 15.4% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,081 Cr
+15.4% YoY
EBITDA
₹185 Cr
+21.9% YoY
Profit After Tax
₹106 Cr
+28.1% YoY
Net Worth
₹935 Cr
+11.6% YoY
Total Assets
₹1,217 Cr
+6.1% YoY
Total Debt
₹262 Cr
-9.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,081937879737555408565
Revenue growth+15.4%+6.6%+19.1%+32.9%+35.9%-27.7%-
EBITDA18515213393.9567.4535.1961.47
EBITDA margin+17.1%+16.2%+15.1%+12.7%+12.2%+8.6%+10.9%
Profit before tax13910868.4350.6137.187.5230.64
Net profit10682.6848.9637.7632.226.1519.87
Net profit margin+9.8%+8.8%+5.6%+5.1%+5.8%+1.5%+3.5%
EPS (₹)6.556.003.622.882.404.9014.95
Balance sheet
Total assets1,2171,147786703571475433
Net worth935838448403359320313
Total debt262290320286201147113
Cash & bank20639661.3450.9427.7031.1215.65
Net working capital19736029.45(2.53)13.8513.48(6.71)
Cash flow
Cash from operations13215610912759.5327.2656.08
Cash from investing(90.03)(393)(88.14)(158)(107)(37.42)(26.29)
Cash from financing(50.10)264(28.98)38.2244.2217.72(27.42)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue287279272275255240232241
Revenue growth (YoY)+12.7%+16.4%+17.2%+13.8%+14.2%---
Other income5.377.797.467.656.9312.358.807.44
EBITDA56.4451.6041.4950.6241.3935.8937.4642.26
EBITDA margin+19.6%+18.5%+15.2%+18.4%+16.2%+15.0%+16.1%+17.5%
Depreciation12.7312.7612.4411.7111.1611.7411.4511.17
Interest6.466.376.757.197.387.838.007.98
Profit before tax42.6240.2629.7639.3729.7828.6726.8130.55
Tax11.199.977.539.388.595.746.218.42
Net profit31.4330.2922.2329.9921.1922.9320.6022.13
EPS (₹)1.981.901.411.901.351.451.311.41
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,060913845714545402563
Revenue growth+16.1%+8.1%+18.3%+31.1%+35.5%-28.6%-
EBITDA18215012893.7767.1635.0462.24
EBITDA margin+17.2%+16.4%+15.2%+13.1%+12.3%+8.7%+11.1%
Profit before tax13910968.0552.8438.798.9031.97
Net profit10683.5548.9938.7432.936.3320.49
Net profit margin+10.0%+9.2%+5.8%+5.4%+6.0%+1.6%+3.6%
EPS (₹)6.536.073.622.962.465.3515.43
Balance sheet
Total assets1,2131,135767683560465428
Net worth939842452406362322314
Total debt260280305268190137108
Cash & bank20639357.9448.3327.1128.8515.24
Net working capital19135319.61(8.80)12.4111.79(6.52)
Cash flow
Cash from operations12915010812960.6727.2956.49
Cash from investing(96.02)(396)(89.91)(153)(106)(33.91)(21.52)
Cash from financing(40.77)274(26.10)29.7343.6512.30(33.01)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue282274267270250235227235
Revenue growth (YoY)+12.9%+16.6%+17.7%+15.0%+15.2%---
Other income5.407.687.497.786.9612.238.807.50
Total expenses227224226220209199190193
EBITDA55.4950.2940.7250.1640.8835.5436.8341.78
EBITDA margin+19.7%+18.4%+15.2%+18.6%+16.4%+15.1%+16.2%+17.8%
Depreciation12.3512.3812.0511.2410.6611.2510.9410.60
Interest6.426.316.596.937.117.537.657.60
Profit before tax42.1239.2829.5739.7730.0728.9927.0431.08
Tax11.069.737.069.818.655.796.268.52

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 03 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue287279272275255240232241
Revenue growth (YoY)+12.7%+16.4%+17.2%+13.8%+14.2%---
Other income5.377.797.467.656.9312.358.807.44
EBITDA56.4451.6041.4950.6241.3935.8937.4642.26
EBITDA margin+19.6%+18.5%+15.2%+18.4%+16.2%+15.0%+16.1%+17.5%
Depreciation12.7312.7612.4411.7111.1611.7411.4511.17
Interest6.466.376.757.197.387.838.007.98
Profit before tax42.6240.2629.7639.3729.7828.6726.8130.55
Tax11.199.977.539.388.595.746.218.42
Net profit31.4330.2922.2329.9921.1922.9320.6022.13
EPS (₹)1.981.901.411.901.351.451.311.41
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,081937879737555408565
Revenue growth+15.4%+6.6%+19.1%+32.9%+35.9%-27.7%-
Other income29.8332.997.357.343.906.774.60
Total expenses896785746643487373504
Employee cost16614813912110483.99103
EBITDA18515213393.9567.4535.1961.47
EBITDA margin+17.1%+16.2%+15.1%+12.7%+12.2%+8.6%+10.9%
Depreciation48.0745.1640.3231.0022.1921.5122.63
Interest27.6931.9431.2919.6811.9812.9312.80
Profit before tax13910868.4350.6137.187.5230.64
Tax35.4625.4919.3112.605.781.3711.17
Net profit10682.6848.9637.7632.226.1519.87
Net profit margin+9.8%+8.8%+5.6%+5.1%+5.8%+1.5%+3.5%
EPS (₹)6.556.003.622.882.404.9014.95
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital15.8313.7613.5913.4113.2413.2413.24
Reserves & surplus919503435390346307300
Shareholders' funds (net worth)935838448403359320313
Minority interest5.975.886.334.541.841.550.47
Secured loans22724025424218412797.79
Unsecured loans34.7049.8366.7044.3217.6419.3115.32
Total debt262290320286201147113
Total liabilities1,2171,147786703571475433
Assets
Gross block1,037938885742600477467
Net block804745719605489383393
Capital work in progress28.6540.4033.4594.7264.1781.0655.69
Investments0.000.000.000.000.000.000.00
Inventories13.429.9810.0813.9912.409.6210.75
Sundry debtors12010194.8293.2873.4154.7276.60
Cash & bank balances20639661.3450.9427.7031.1215.65
Loans & advances27.6828.2813.8612.1513.5414.0114.51
Total current assets367535180170127109118
Total current liabilities17017515117311395.99124
Net working capital19736029.45(2.53)13.8513.48(6.71)
Total assets1,2171,147786703571475433
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash41.5914.6122.8715.7019.1611.619.24
Net cash from operating activities13215610912759.5327.2656.08
Net cash from investing activities(90.03)(393)(88.14)(158)(107)(37.42)(26.29)
Net cash from financing activities(50.10)264(28.98)38.2244.2217.72(27.42)
Net change in cash(8.18)26.98(8.26)7.17(3.46)7.552.37
Closing cash20639661.3450.9427.7031.1215.65
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+15.4%+6.6%+19.1%+32.9%+35.9%-27.7%-
EBITDA growth+21.9%+14.4%+41.2%+39.3%+91.7%-42.8%-
PBT growth+29.2%+57.4%+35.2%+36.1%+394.4%-75.5%-16.7%
Net income growth+28.1%+68.9%+29.7%+17.2%+423.9%-69.1%-
Revenue CAGR (3Y)+13.6%+19.1%+29.1%+9.3%+0.5%--
EBITDA CAGR (3Y)+25.4%+31.0%+55.7%+15.2%+1.9%--
Profitability & leverage
Net income margin+9.6%+8.8%+5.6%+5.2%+5.7%+1.5%+3.5%
Return on capital employed+15.1%+15.7%+14.9%+12.4%+10.8%+4.5%+12.2%
Return on net worth+12.7%+14.3%+13.7%+12.1%+11.5%+2.3%+8.2%
Debt / equity0.340.530.850.780.640.520.48
Long-term debt / equity0.290.470.750.680.550.410.28
Interest cover20.2129.9533.8731.2626.4794.5232.96
Efficiency & per share
Fixed asset turnover1.181.111.181.221.181.011.47
Inventory turnover92.4193.4173.0055.8950.3940.1063.88
Debtors turnover9.799.559.348.858.666.227.28
EPS (₹)6.556.003.622.882.404.9014.95
Dividend per share (₹)0.450.450.450.450.000.000.00
Book value per share (₹)54.6932.6028.0025.0322.10191.73186.78
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue282274267270250235227235
Revenue growth (YoY)+12.9%+16.6%+17.7%+15.0%+15.2%---
Other income5.407.687.497.786.9612.238.807.50
Total expenses227224226220209199190193
EBITDA55.4950.2940.7250.1640.8835.5436.8341.78
EBITDA margin+19.7%+18.4%+15.2%+18.6%+16.4%+15.1%+16.2%+17.8%
Depreciation12.3512.3812.0511.2410.6611.2510.9410.60
Interest6.426.316.596.937.117.537.657.60
Profit before tax42.1239.2829.5739.7730.0728.9927.0431.08
Tax11.069.737.069.818.655.796.268.52
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,060913845714545402563
Revenue growth+16.1%+8.1%+18.3%+31.1%+35.5%-28.6%-
Other income29.9032.927.297.133.886.784.57
Total expenses878763717621478367501
Employee cost16214413411710282.49102
EBITDA18215012893.7767.1635.0462.24
EBITDA margin+17.2%+16.4%+15.2%+13.1%+12.3%+8.7%+11.1%
Depreciation46.3343.0238.0329.4721.0820.6522.33
Interest26.9430.4829.5918.5911.1712.2712.51
Profit before tax13910968.0552.8438.798.9031.97
Tax35.2425.7918.9013.186.231.8211.54
Net profit10683.5548.9938.7432.936.3320.49
Net profit margin+10.0%+9.2%+5.8%+5.4%+6.0%+1.6%+3.6%
EPS (₹)6.536.073.622.962.465.3515.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital15.8313.7613.5913.4113.2413.2413.24
Reserves & surplus923507438393348308301
Shareholders' funds (net worth)939842452406362322314
Secured loans22623123822417311892.79
Unsecured loans34.7049.8366.7044.3217.6419.3115.32
Total debt260280305268190137108
Total liabilities1,2131,135767683560465428
Assets
Gross block1,014914858716585464461
Net block790729699584476372387
Capital work in progress32.9540.4033.4594.6864.0581.0155.69
Investments15.0215.0215.0211.705.594.291.69
Inventories13.019.339.0912.7511.759.2710.53
Sundry debtors11192.8683.5084.8169.6452.9776.51
Cash & bank balances20639357.9448.3327.1128.8515.24
Loans & advances27.7628.1413.4812.3414.1314.6114.47
Total current assets358524164158123106117
Total current liabilities16717114416711093.91123
Net working capital19135319.61(8.80)12.4111.79(6.52)
Total assets1,2131,135767683560465428
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash41.0113.2621.6715.1116.8911.209.24
Net cash from operating activities12915010812960.6727.2956.49
Net cash from investing activities(96.02)(396)(89.91)(153)(106)(33.91)(21.52)
Net cash from financing activities(40.77)274(26.10)29.7343.6512.30(33.01)
Net change in cash(7.97)27.76(8.41)6.55(1.77)5.691.96
Closing cash20639357.9448.3327.1128.8515.24
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+16.1%+8.1%+18.3%+31.1%+35.5%-28.6%-
EBITDA growth+21.5%+16.7%+36.9%+39.6%+91.7%-43.7%-
PBT growth+26.9%+60.6%+28.8%+36.2%+335.8%-72.2%-13.7%
Net income growth+26.6%+70.6%+26.5%+17.6%+420.2%-69.1%-
Revenue CAGR (3Y)+14.1%+18.8%+28.1%+8.3%-0.1%-7.2%+7.1%
EBITDA CAGR (3Y)+24.8%+30.7%+54.2%+14.6%+1.6%-16.2%+6.3%
Profitability & leverage
Net income margin+9.8%+9.1%+5.8%+5.6%+6.0%+1.8%+3.6%
Return on capital employed+15.0%+15.8%+14.9%+12.9%+11.2%+4.8%+12.5%
Return on net worth+12.6%+14.4%+13.6%+12.5%+11.9%+2.5%+8.8%
Debt / equity0.330.510.790.720.600.490.47
Long-term debt / equity0.280.450.710.640.510.380.28
Interest cover19.8528.5332.7528.9124.2485.2731.35
Efficiency & per share
Fixed asset turnover1.181.121.171.221.191.011.48
Inventory turnover94.9499.1677.4058.3151.8340.6164.46
Debtors turnover10.3810.3610.049.258.896.217.26
EPS (₹)6.536.073.622.962.465.3515.43
Dividend per share (₹)0.450.450.450.450.000.000.00
Book value per share (₹)54.9432.9028.2425.2822.26192.81187.41

To see the full year-wise statements and ratios of Artemis Medicare Services Limited, buy the company report.

Board of directors of Artemis Medicare Services Limited

Artemis Medicare Services has 10 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shalini Kanwar ChandDirector24 Jan 200719 Years 9 MonthsCurrent
Onkar Kanwar
Also directs: Apollo Tyres Limited., Osk Consultants LLP, PTL Enterprises Limited and 3 more
Director14 Sep 200620 Years 1 MonthsCurrent
Devlina Chakravarty
Also directs: Classic Industries and Exports Limited, Artemis Cardiac Care Private Limited
Managing Director02 Apr 201511 Years 7 MonthsCurrent
Sanjib SenDirector03 Aug 20206 Years 3 MonthsCurrent
Neeraj Singh Kanwar
Also directs: Apollo Tyres Limited., PTL Enterprises Limited, Sunrays Properties and Investments Company Private Limited and 2 more
Director17 Jan 200818 Years 9 MonthsCurrent
Sunam Sarkar
Also directs: Apollo Tyres Limited.
Director12 May 20251 Years 5 MonthsCurrent
Showing 6 of 10 current directors. View all directors

Peer comparison

Artemis Medicare Services Limited is compared with the 8 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Malabar Institute of Medical Sciences Ltd₹1,127.68 Cr (FY 2025)11.0%Kozhikode, Kerala, India
Shalby Limited₹1,114.55 Cr (FY 2025)17.0%Ahmedabad, Gujarat, India
Artemis Medicare Services Limitedthis company₹1,081.24 Cr (FY 2026)₹105.9 Cr9.8%15.4%2,023New Delhi, Delhi, India
Sahyadri Hospitals Private Limited₹1,046.76 Cr (FY 2025)24.0%Pune, Maharashtra, India
Crosslay Remedies Limited₹1,001.64 Cr (FY 2025)21.0%Gurgaon, Haryana, India
Yatharth Hospital & Trauma Care Services Limited₹896.66 Cr (FY 2025)31.0%Centre, Delhi, India
Zydus Hospitals and Healthcare Research Private Limited₹876.25 Cr (FY 2025)24.0%Ahmedabad, Gujarat, India
Kailash Healthcare Limited₹764.37 Cr (FY 2025)12.0%Delhi, India
Wockhardt Hospitals Limited₹738.83 Cr (FY 2025)14.0%Mumbai, Maharashtra, India

To see the full peer comparison of Artemis Medicare Services Limited, buy the company report.

Auditor

Artemis Medicare Services Limited is audited by T R Chadha & Co LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
T R Chadha & Co LLPFY 2023006711N/N500028

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 58.40%, foreign institutional investors hold 12.30%, domestic institutional investors hold 8.50% and retail and other public shareholders hold 20.80%.

Promoters: 58.40%DII (Domestic Institutional): 8.50%FII (Foreign Institutional): 12.30%Retail & Others: 20.80%
Sep 2026
QUARTER
58.40% Promoters
8.50% DII (Domestic Institutional)
12.30% FII (Foreign Institutional)
20.80% Retail & Others
Promoter holding - history
Now 58.40% · Sep 2026High 66.50% · Dec 2025Low 58.40% · Mar 2026
57%59.8%62.5%65.3%68%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 66.50%Mar 2026: 58.40%Jun 2026: 58.40%Sep 2026: 58.40%66.50%58.40%58.40%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters58.40%58.40%58.40%66.50%
Public41.60%41.60%41.60%33.50%

Charges & borrowings

Open charges
₹394.37 Cr
Satisfied charges
₹485.37 Cr
Breakdown by lending institutions
Axis Bank Limited₹143.70 Cr
Others₹132.80 Cr
Hdfc Bank Limited₹117.87 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Mar 2026101260284Hdfc Bank Limited₹38.84 LakhOpen
09 Feb 2026101247261Hdfc Bank Limited₹47.48 LakhOpen
20 Mar 2024100898748Axis Bank Limited₹103.7 CrOpen
15 Dec 2023100838264Hdfc Bank Limited₹2 CrOpen
22 Dec 2022100661381Others₹70 CrOpen

To see the full charge records of Artemis Medicare Services Limited, buy the company report.

Total charge records: 33 View all charges

Deals & funding

Artemis Medicare Services Limited has 6 deals on record (2 acquisitions, 1 convertible or debt financing, 1 funding round), with disclosed funding of ₹372.35 Cr; the latest was in September 2026.

Total deals
6
Acquisitions
2
Convertible or debt financing
1
Funding round
1
Secondary share transfer
1
Disclosed funding
₹372.35 Cr

Deals on record (5 of 6)

WhenDealAmountParties
Sep 2026Market trade₹36.76 CrBuyer: Microcurves Trading Private Limited
Seller: Microcurves Trading Private Limited
Dec 2015Secondary share transferUndisclosedBuyer: Artemis Health Sciences Limited
Seller: PTL Enterprises Limited
Aug 2011Funding round₹42.35 CrInvestors: PTL Enterprises Limited
Mar 2007Acquisition₹90 CrBuyer: Artemis Health Sciences Limited
Feb 2006AcquisitionUndisclosedBuyer: Artemis Health Sciences Limited
Seller: PTL Enterprises Limited

To see the full deal history of Artemis Medicare Services Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Artemis Medicare Services Limited was last rated by Care on 01 Sep 2022.

Rating agencyRated onRating
Care01 Sep 2022

To see the full credit ratings and regulatory alerts of Artemis Medicare Services Limited, buy the company report.

MSME payment delays

Artemis Medicare Services Limited has 4 MSME Form 1 returns on record for the period ending Mar 2019, listing 99 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 15)

SupplierAmount dueDue sinceReported on
Neurocare & Solution
an individual supplier
an individual supplier
Ved Med Software and Trading Private Limited
an individual supplier

To see the full MSME payment records of Artemis Medicare Services Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Artemis Medicare Services has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
Artemis Cardiac Care Private LimitedU85110DL2019PTC344351

To see the full group structure of Artemis Medicare Services Limited, buy the company report.

Employees & EPFO

Artemis Medicare Services Limited has a workforce of 2,023 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.

Employee count
2,023
Active EPFO establishments
1
Employee growth
4.28%

GST

Artemis Medicare Services has 5 GST registrations: 3 active and 2 cancelled or inactive.

Total GSTINs
5
Active
3
Cancelled / inactive
2
GSTINStateStatusRegistered on
07AAFCA0130M1ZZDelhiActive01 Jul 2017
06AAFCA0130M1Z1HaryanaActive01 Jul 2017
08AAFCA0130M1ZXRajasthanActive13 Oct 2022

To see the full GST registrations and return filing status of Artemis Medicare Services Limited, buy the company report.

Recent activity

Artemis Medicare Services Limited has 40 board changes on record since 2006: 26 appointments and 14 cessations. The latest: Tapan Mitra was appointed as Additional Director on 08 May 2026.

Appointed
Tapan Mitra was appointed as Additional Director.
Filing
Artemis Medicare Services Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.39 Cr with Charge ID 101260284 was registered on 11 Mar 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.47 Cr with Charge ID 101247261 was registered on 09 Feb 2026.
Charges
A charge registered on 29 Nov 2019 via Charge ID 100314584 with Axis Bank Limited was fully satisfied on 29 Nov 2025.
AGM
Artemis Medicare Services Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records.
Ceased
Deepa Gopalan Wadhwa ceased to be Director.
Ceased
Nirmal Kumar Ganguly ceased to be Director.
Appointed
Sunam Sarkar was appointed as Director.
Appointed
Vinod Rai was appointed as Director.
Appointed
Akshaykumar Narendrasinhji Chudasama was appointed as Director.
Appointed
Pallavi Shardul Shroff was appointed as Director.

98 earlier events are in the company report.

News

ARTEMISMED: Q2 REVENUE 3.1B RUPEES VS 2.75B (YOY)
30 Oct 2026 · Exchange Update
ARTEMISMED: Q2 CONS NET PROFIT 310M RUPEES VS 299.7M (YOY)
30 Oct 2026 · Exchange Update
ARTEMISMED: Q2 EBITDA 548M RUPEES VS 506.1M (YOY); Q2 EBITDA MARGIN 17.62% VS 18.43% (YOY)
30 Oct 2026 · Exchange Update

Frequently asked questions

Artemis Medicare Services is an active public limited company based in New Delhi, Delhi, India. The company works in hospitals, within the healthcare industry. It was incorporated on 18 May 2004 (22+ years old) and is registered under CIN L85110DL2004PLC126414. Listed on BSE: 542919 and NSE: ARTEMISMED.

Artemis Medicare Services reported revenue of ₹1,081.24 Cr for FY 2025-26 (up 15.4% YoY) based on consolidated financials.

Artemis Medicare Services has 10 current directors:

The latest financial statements of Artemis Medicare Services on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 July 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Artemis Medicare Services is 07AAFCA0130M1ZZ, registered in Delhi. The company has 5 GST registrations in all, of which 3 are active and 2 are cancelled or inactive. Other active GSTINs include 06AAFCA0130M1Z1 (Haryana), 08AAFCA0130M1ZX (Rajasthan).

The CIN (Corporate Identification Number) of Artemis Medicare Services is L85110DL2004PLC126414. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Artemis Medicare Services is a listed company as per MCA records. Its shares are listed on both BSE (code: 542919) and NSE (symbol: ARTEMISMED).

Artemis Medicare Services has 38 court cases on record: 23 filed by the company and 16 filed against it. 11 are pending. Most are in the high courts.

Artemis Medicare Services was incorporated on 18 May 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.

Artemis Medicare Services has 6 deals on record (2 acquisitions, 1 convertible or debt financing, 1 funding round), with disclosed funding of ₹372.35 Cr; the latest was in September 2026.

The peers of Artemis Medicare Services by revenue are Malabar Institute of Medical Sciences Ltd, Shalby Limited, Sahyadri Hospitals Private Limited, Crosslay Remedies Limited, Yatharth Hospital & Trauma Care Services Limited and 3 more, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities).

Tapan Mitra was appointed as Additional Director on 08 May 2026. Deepa Gopalan Wadhwa ceased to be Director on 21 May 2025. Nirmal Kumar Ganguly ceased to be Director on 12 May 2025. Artemis Medicare Services has 40 board changes on record in total.